The economic side of an oral sugar lowering therapy intensification by glucagon-like peptidt-1 receptor agonists

Autor: S. K. Zyryanov, I. N. Dyakov

Publikováno v: Качественная клиническая практика, Vol 0, Iss 4, Pp 4-15 (2022)

The effective control of Diabetes Mellitus (DM) is an actual problem from optimal expenditures of health care system point of view. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are one of the modern options for glycemia control in DM Type 2 a

Externí odkaz: https://doaj.org/article/a3d973c7b4614d8a91739ad431ebba26

Triple therapy for obese patients with type 2 diabetes: evaluating effectiveness of the metformin + exenatide + glibenclamide combination

Autor: M. B. Antsiferov, O. M. Koteshkova, M. V. Shestakova

Publikováno v: Медицинский совет, Vol 0, Iss 11, Pp 66-71 (2015)

The questions of phased management of metabolic disorders in patients with type 2 diabetes with obesity are considered. The advantages of various triple therapy regimens depending on the objectives and key pathogenic defects are demonstrated. Results

Externí odkaz: https://doaj.org/article/36883751b4f54af29fd5292b979a165d

Efficacy of GLP-1 analog to achieve metabolic control and correction of body weight in patients with type 2 diabetes mellitus

Autor: T. V. Saprina, T. K. Gudkova, V. A. Stolyarova, S. Yu. Martynova, N. G. Dudarkova, T. G. Yaroshevskaya, Yu. A. Kabirova, O. A. Pavlenko, I. N. Vorozhtsova

Publikováno v: Бюллетень сибирской медицины, Vol 10, Iss 6, Pp 114-119 (2011)

Obesity associated with the enhanced risk of cardiovascular disorders plays a key role in the evolvement and progression of type 2 diabetes mellitus (DM2). Incretin mimetics are the sole class of hypoglycemic agents that not only effectively correct

Externí odkaz: https://doaj.org/article/247c1e2a07d64f849e28b20a3ecf8927

ГІСТОЛОГІЧНІ ТА ЕЛЕКТРОННОМІКРОСКОПІЧНІ ДОСЛІДЖЕННЯ ПІДШЛУНКОВОЇ ЗАЛОЗИ ПРИ ЛІКУВАННІ СТРЕПТОЗОТОЦИНОВОГО ЦУКРОВОГО ДІАБЕТУ ЕКСЕНАТИДОМ

Autor: Ivantsiv, O. R., Popovych, Yu. I., Miskiv, V. A., Pertsovych, V. M., V.M. Zhurakivskyi, V. M.

Publikováno v: Clinical anatomy and operative surgery; Том 15, № 1 (2016): Clinical Anatomy and Operative Surgery; 11-14
Клиническая анатомия и оперативная хирургия; Том 15, № 1 (2016): Клиническая анатомия и оперативная хирургия; 11-14
Клінічна анатомія та оперативна хірургія; Том 15, № 1 (2016): Клінічна анатомія та оперативна хірургія; 11-14

To study the impact of Exenatid on the ultrastructural organization of the pancreatic islets the medication was injected to diabetic male rats on 14th day of the development of Streptozotocin-induced diabetes. Material sampling was done on 28th, 42nd

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::e4b11a9999e388087cef038de3164722
http://kaos.bsmu.edu.ua/article/view/1727-0847.15.1.2016.2

Влияние синтетических миметиков глюкагоноподобного пептида-1 на осмо- и ионорегулирующие функции почек крыс

Глюкагоноподобный пептид-1 регулирует углеводный обмен и влияет на водно-солевой баланс. Представляет существенный интерес синтез миме

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1f28bc8f8ea6cd51888adb9f440c80e5